This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Pulmonary atresia Pulmonary Artery Atresia


1. History

Pulmonary artery atresia is one of the severe cyanotic congenital heart defects and was first described in autopsy reports in the late 19th century. In 1945, when Blalock and Taussig introduced the subclavian artery-to-pulmonary artery shunt (Blalock-Taussig shunt), a turning point was reached in the palliative treatment of patients with cyanotic heart defects. This procedure greatly improved the survival of patients with heart defects with reduced pulmonary blood flow, such as pulmonary atresia and tetralogy of Fallot.

Pulmonary atresia shows various anatomic forms and is broadly divided according to the presence of a ventricular septal defect into ① the type with ventricular septal defect (PA/VSD, the extreme form of tetralogy of Fallot) and ② the type without ventricular septal defect (PA/IVS, intact interventricular septum). PA/IVS has a distinctive pathophysiology because it is accompanied by right ventricle-to-coronary artery fistulas (RVCA fistula) and right ventricle-dependent coronary circulation (RVDCC).

Since the 1990s, percutaneous balloon pulmonary valvuloplasty and radiofrequency perforation techniques have been introduced, making it possible to open the atretic pulmonary valve in a minimally invasive manner. Complete surgical repair is approached through right ventricular outflow tract reconstruction in PA/VSD, and through single-ventricle palliation or biventricular repair in PA/IVS.

2. Causes

The causes of pulmonary atresia differ somewhat according to morphologic type.

PA/IVS (intact ventricular septum):

PA/VSD (with ventricular septal defect):

Genetic factors: may be associated with NKX2.5, GATA4, JAG1 (Alagille syndrome), 22q11.2 deletion and others. Maternal diabetes, lupus and anticonvulsant exposure are also known risk factors.

3. Genetics

The genetics of pulmonary atresia differ according to the type of associated anomalies.

PA/VSD + 22q11.2 microdeletion (DiGeorge/velocardiofacial syndrome):

JAG1 variants (Alagille syndrome):

Others:

PA/IVS often occurs in isolation, and its association with specific genetic syndromes is lower than that of PA/VSD. Chromosomal microarray and next-generation sequencing (NGS panel) are recommended for comprehensive genetic evaluation.

4. General epidemiology

Pulmonary atresia is relatively rare among congenital heart defects.

PA/IVS:

PA/VSD:

In Korea, several dozen patients are diagnosed annually under code Q25.5, and it is eligible for Special Copayment Reduction V149. Because intensive treatment at specialized pediatric cardiac centers is required, most patients are concentrated in tertiary hospitals in Seoul and the capital region.

With the spread of prenatal ultrasound, the prenatal diagnosis rate has increased, and prenatal diagnosis is advantageous for planning delivery and initial treatment.

5. Pathophysiology

The pathophysiology of pulmonary atresia differs greatly by type.

Pathophysiology of PA/IVS:

Pathophysiology of PA/VSD:

6. Symptoms

The symptoms of pulmonary atresia vary according to type and severity.

Neonatal symptoms of PA/IVS:

Symptoms of PA/VSD:

Common symptoms: abnormal heart sounds (single second heart sound), cyanotic spells (similar to tetralogy of Fallot in PA/VSD).

7. Signs

Physical examination findings in patients with pulmonary atresia:

PA/IVS:

PA/VSD:

Electrocardiogram: left ventricular hypertrophy in PA/IVS (reflecting right ventricular hypoplasia). Right ventricular hypertrophy in PA/VSD.

Chest X-ray: decreased pulmonary vascular markings, cardiomegaly (PA/IVS), uneven pulmonary vascular markings (PA/VSD with MAPCA).

Echocardiography: evaluates pulmonary valve atresia, right ventricular size, tricuspid annulus size, coronary artery fistulas, presence of the ductus arteriosus and so on.

8. Screening

Screening tests for early detection of pulmonary atresia:

Prenatal ultrasound:

Newborn Pulse Oximetry Screening:

When there is a family history or risk factors:

9. Diagnosis

Diagnosis and preoperative evaluation of pulmonary atresia:

Echocardiography:

Cardiovascular CT angiography (CTA):

Cardiac Catheterization:

MRI: used complementarily for assessment of ventricular volumes and pulmonary artery branch anatomy.

10. Treatment

Treatment of pulmonary atresia differs greatly by type.

Common initial management:

Treatment of PA/IVS:

Treatment of PA/VSD:

11. Prognosis

The prognosis of pulmonary atresia depends greatly on type, right ventricular size and the presence of RVDCC.

Prognosis of PA/IVS:

Prognosis of PA/VSD:

Long-term complications:

12. Prevention

Prevention strategies for pulmonary atresia:

Prenatal care:

Genetic counseling:

Newborn screening:

Regular follow-up:

13. References

  1. Hanley FL, et al. Outcomes in critically ill neonates with pulmonary stenosis and intact ventricular septum: a multiinstitutional study. J Am Coll Cardiol. 1993;22(1):183-192. PMID:8509544
  2. Calder AL, et al. Pulmonary atresia with intact ventricular septum: review of the anatomy, diagnosis and natural history. Pediatr Cardiol. 1987;8(3):219-226. PMID:3658424
  3. Alwi M, et al. Pulmonary atresia with intact ventricular septum: percutaneous radiofrequency-assisted valvotomy and balloon dilatation versus surgical valvotomy and Blalock-Taussig shunt. J Am Coll Cardiol. 2000;35(2):468-476. PMID:10676695
  4. Reddy VM, et al. One-stage complete unifocalization in infants: when should the ventricular septal defect be closed? J Thorac Cardiovasc Surg. 1997;113(5):858-868. PMID:9159621
  5. Guleserian KJ, et al. Natural history of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries. Circulation. 2006;113(9):1185-1192. PMID:16505170
  6. Daubeney PE, et al. Pulmonary atresia with intact ventricular septum: predictors of early and medium-term outcome in a population-based study. J Thorac Cardiovasc Surg. 2005;130(4):1071-1075. PMID:16214524
  7. Tchervenkov CI, et al. The nomenclature, definition and classification of hypoplastic left heart syndrome. Cardiol Young. 2000;10(1):67-74. PMID:10696261
  8. Moon-Grady AJ, et al. Is there a role for routine genetic analysis in fetuses with pulmonary atresia/intact ventricular septum? Pediatr Cardiol. 2010;31(8):1187-1195. PMID:20617310
  9. Baffa JM, et al. Coronary artery abnormalities and right ventricular histology in hypoplastic right heart syndrome. J Am Coll Cardiol. 1992;20(2):350-358. PMID:1634672
  10. Powell AJ, et al. Systemic-to-pulmonary collateral vessels and neo-aortic arch obstruction: implications for staging of the arterial switch operation. J Thorac Cardiovasc Surg. 1995;109(5):954-960. PMID:7739253